MoneyWorks4Me

The sales for the September 2025 quarter moved down to Rs. 3569.00 millions as compared to Rs. 4368.80 millions during the year-ago period.The Net Loss for the quarter ended September 2025 is Rs. -399.30 millions as compared to Net Profit of Rs. 433.70 millions of corresponding quarter ended September 2024The company reported a degrowth in operating Profit to 291.00 millions from 715.80 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202509 202409 % Var 202509 202409 % Var 202503 202403 % Var
Sales 3569.00 4368.80 -18.31 7411.50 8266.30 -10.34 17357.00 14421.60 20.35
Other Income 214.00 70.80 202.26 256.50 158.50 61.83 408.30 303.90 34.35
PBIDT 291.00 715.80 -59.35 590.90 1205.40 -50.98 2947.10 813.00 262.50
Interest 36.80 18.20 102.20 56.10 32.00 75.31 76.20 104.20 -26.87
PBDT -77.20 697.60 -111.07 203.40 1173.40 -82.67 2910.90 132.70 2093.59
Depreciation 301.10 263.90 14.10 600.40 524.90 14.38 1084.10 1054.50 2.81
PBT -378.30 433.70 -187.23 -397.00 648.50 -161.22 1826.80 -921.80 -298.18
TAX 21.00 0.00 0.00 20.80 0.00 0.00 197.20 0.00 0.00
Deferred Tax 21.00 0.00 0.00 16.40 0.00 0.00 197.20 0.00 0.00
PAT -399.30 433.70 -192.07 -417.80 648.50 -164.43 1629.60 -921.80 -276.78
Equity 140.80 140.80 0.00 140.80 140.80 0.00 140.80 140.80 0.00
PBIDTM(%) 8.15 16.38 -50.24 7.97 14.58 -45.33 16.98 5.64 201.19
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..